Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview

Sonoma Pharmaceuticals

04/02/2025 21:03

* Sonoma Pharmaceuticals Inc  SNOA.OQ   SNOA.O  is expected
to show a rise in quarterly revenue when it reports  results on
February 6 (estimated) for the period ending December 31 2024
    * The Boulder Colorado-based  company is expected to report
a
29.4% increase in revenue to $4.06 million from $3.14 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Sonoma Pharmaceuticals
Inc is
for a loss of 69 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sonoma
Pharmaceuticals Inc is $17.00​, above​ its last closing price
of $2.58. ​​​

This summary was machine generated February 4 at 21:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)